USMLE Step 2: This month ’s question to beat
Getting ready for the United States Medical Licensing Examination ® (USMLE®) Step 2 is no easy feat, but we’re sharing expert insights to help give you a leg up. Take a look at the exclusive scoop on this month’s most-missed USMLE Step 2 test prep question. Think you have what it takes to rise above your peers? Test your USMLE knowledge, and view an expert v ideo explanation of the answer from Kaplan Medical. Once you ’ve got this question under your belt, be sure to test your knowledge with other posts in this series . Ready. Set. Go. This month ’s question that stumped most students: A 14-year-old girl comes to the physician because of heavy menstrual bleeding that began with menarche two years ago. Her menstrual periods last eight to 10 days and occur approximately every 28 days. Her last menstrual period ended three days ago. Vital signs are temperature 37.0 ºC (98.6ºF), blood pressure 110/70 mm Hg, pulse 90/min and respirations 18/min. Physical examination shows a slender, calm girl who is in no distress but appears pale. The remainder of the examination is unremarkable. Laboratory studies show: WBC: 7,000/mm 3 Hb: 9 g/dL Hct: 27% Plt: 250,000/mm 3 Which of the following is the most appropriate next step in management? A. Begin a transfusion of packed red blood cells B. Order a pelvic ultrasound to rule out polycystic ovaries C. Order coagulation profile ...
We're looking to buy another ultrasound machine for the ICU. Anyone with experience to compare the x-porte and the venue? No need to support TEE. Planning to get linear and phased array probes. Intended use would be vascular access and focused echo exams.
Publication date: Available online 7 July 2020Source: Academic RadiologyAuthor(s): Mouhand F.H. Mohamed
Conditions: Cataract; Ultrasound Therapy; Complications Intervention: Device: Eye Scan Ultrasound System (ESUS) Sponsors: University of Coimbra; Fundação para a Ciência e a Tecnologia Not yet recruiting
Condition: Hemophilia A Intervention: Drug: Damoctocog alfa pegol (Jivi, BAY94-9027) Sponsor: Bayer Not yet recruiting
Condition: Rotator Cuff Injury Intervention: Procedure: Ultrasound-guided drug injection Sponsor: Peking University Third Hospital Recruiting
Conditions: Internet Based Wellness Program; Obesity; Adult Population Intervention: Behavioral: Internet Wellness Intervention for Aging Sponsor: North Dakota State University Not yet recruiting
This article reviews the emerging field of telehealth for the treatment of pediatric obesity. The challenges of the current approach to pediatric obesity care are explored, and the potential benefits of incorporating and implementing telehealth in this field are presented. The care of pediatric patients with obesity is particularly well suited for telehealth.
This study showed that ultrasound triggering and GSH responsive PSP@MB might provide a novel strategy for OCSCs treatment via sonoporation and enhanced-endocytosis. PMID: 32627597 [PubMed - in process]
Authors: Holanger M, Kjeldsen SE, Jamerson K, Julius S, HOT Study investigators Abstract PURPOSE: The Hypertension Optimal Treatment (HOT) Study investigated the relationship between target office diastolic blood pressure (BP) ≤80, ≤85 or ≤90 mmHg and cardiovascular morbidity and mortality in 18,790 patients aged 50-80 years. The home BP sub-study enrolled 926 patients and the aim was to clarify whether the separation into the BP target groups in the office prevailed in the out-of-office setting. The present study aimed to identify variables that characterised masked uncontrolled hypertension...
We report a novel homozygous GFI1B (Thr174Ile) variant located in the first Zinc finger domain of GFI1B in two sisters of Palestinian ancestry born to consanguineous parents. They experienced severe bleeding tendency at moderately reduced platelet counts. Flow cytometry and immunofluorescent microscopy confirmed the diagnostic features of GFI1B associated IT: a reduced content of alpha granules and aberrant expression of the stem cell marker CD34 on platelets. Transcription factor GFI1B is differentially expressed during hemato- and lymphopoiesis. In addition, to platelet function investigations, we present results of lymp...